Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2018

Jul 11, 2018

31949_dirs_2018-07-11_52a421f7-a82b-42e3-b248-0c7b6fb5c5bb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-07-01

Reporting Person: Shah Pritesh (Chief Commercial Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 5231 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Options to Buy Ordinary Shares $27.60 2028-05-01 Ordinary Shares (30000) Direct
Options to Buy Ordinary Shares $21.15 2028-02-27 Ordinary Shares (67586) Direct
Options to Buy Ordinary Shares $19.25 2027-07-26 Ordinary Shares (50000) Direct
Options to Buy Ordinary Shares $11.85 2027-05-02 Ordinary Shares (50000) Direct
Options to Buy Ordinary Shares $7.15 2027-02-22 Ordinary Shares (65000) Direct
Options to Buy Ordinary Shares $11.46 2026-02-24 Ordinary Shares (24963) Direct
Options to Buy Ordinary Shares $11.46 2026-02-24 Ordinary Shares (10037) Direct
Options to Buy Ordinary Shares $14.37 2025-03-05 Ordinary Shares (17739) Direct
Options to Buy Ordinary Shares $14.37 2025-03-05 Ordinary Shares (5913) Direct
Options to Buy Ordinary Shares $7.48 2024-02-26 Ordinary Shares (59130) Direct
Options to Buy Ordinary Shares $7.03 2023-02-20 Ordinary Shares (8869) Direct
Options to Buy Ordinary Shares $6.72 2022-11-13 Ordinary Shares (23652) Direct
Restricted Stock Units $0.00 2028-05-01 Ordinary Shares (7000) Direct
Restricted Stock Units $0.00 2028-02-27 Ordinary Shares (9259) Direct
Restricted Stock Units $0.00 2027-02-22 Ordinary Shares (39000) Direct

Footnotes

F1: One-quarter of these options will vest on each of May 1, 2019, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates.

F2: One-quarter of these options will vest on each of February 27, 2019, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates.

F3: One-quarter of these options will vest on each of July 26, 2018, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates.

F4: One-quarter of these options will vest on each of May 2, 2018, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates.

F5: One-quarter of these options vest on each of February 22, 2018, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates.

F6: One-quarter of these options vest on each of February 24, 2017, 2018, 2019 and 2020, subject to the reporting person's continued employment through such dates.

F7: Options to buy 1,311 ordinary shares will fully vest and become exercisable on February 24, 2019 and options to buy 8,726 ordinary shares will fully vest and become exercisable on February 24, 2020.

F8: Options to buy 17,739 ordinary shares are vested and currently exercisable as of the date hereof.

F9: Options to buy 5,913 ordinary shares will fully vest and become exercisable on February 25, 2019.

F10: Options to buy 59,130 ordinary shares are vested and currently exercisable as of the date hereof.

F11: Options to buy 8,869 ordinary shares are vested and currently exercisable as of the date hereof.

F12: Options to buy 23,652 ordinary shares are vested and currently exercisable as of the date hereof.

F13: One-third of these restricted stock units are scheduled to vest on each of May 1, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates.

F14: One-third of these restricted stock units are scheduled to vest on each of February 27, 2019, 2020 and 2021, subject to the reporting person's continued employment through such dates.

F15: One-third of these restricted stock units are scheduled to vest on each of February 22, 2018, 2019 and 2020, subject to the reporting person's continued employment through such dates.